Biogen is giving up its ownership of Aduhelm, the Alzheimer’s disease treatment whose 2021 approval led to scrutiny and outrage, turning the page on a
Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science,
Psychedelic Alpha’s Josh Hardman speaks with Compass Pathways CEO, Kabir Nath, about a range of topics: from the company’s recently-announced agreements that could shed light on
The TDR Three Takeaways: Monitor next quarter’s earnings for Psychedelics companies with our detailed calendar. Stay updated on upcoming quarterly reporting timelines in the Psychedelic
TDR News Highlights for Wild Wednesday Cannabis TDR News: U.S. Senator Chris Van Hollen (D-Md.) joined Elizabeth Warren (D-Mass.), John Fetterman (D-Pa.), Chuck Schumer (D-N.Y.),
Lucienne Ide, MD, PhD, Founder and CEO of Rimidi Ansley Dalbo, founder of Diabetes – What to Know Whether it’s on TikTok, WhatsApp, Instagram or
The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors,
In late 2022, Sarah Gutilla’s treatment-resistant depression had grown so severe, she was actively contemplating suicide.
Researchers evaluated the incidence of breast cancer among young women between the ages of 20 and 49 years. They assessed the incidence according to age
The evidence for 2000 international units (IU) of vitamin D supplementation per day.